Incyte
INCY
#1169
Rank
HK$153.48 B
Marketcap
HK$781.82
Share price
-1.00%
Change (1 day)
35.25%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): HK$47.75

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$47.81. In 2024 the company made an earnings per share (EPS) of HK$2.42 a decrease over its 2023 EPS that were of HK$20.86.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$47.751871.41%
2024HK$2.42-88.39%
2023HK$20.8673.38%
2022HK$12.03-64.1%
2021HK$33.52-408.63%
2020-HK$10.86-166.83%
2019HK$16.25300%
2018HK$4.06-133.33%
2017-HK$12.19-378.57%
2016HK$4.382700%
2015HK$0.16-106.67%
2014-HK$2.34-44.44%
2013-HK$4.2250%
2012-HK$2.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$57.50 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-71.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30 235.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80 112.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.67-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.94-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.53-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.56-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.80-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA